Dolby Laboratories (DLB) FY2012 results: revenue $933 million, down 2.9% on the year
Dolby Laboratories, Inc. (DLB) reported revenue of $933 million for fiscal 2012, the year ended 28 September 2012, down 2.9% on the year before. Net income was $264 million, down 14.5%, and diluted earnings per share $2.46. The figures are the company's own, from the 10-K it filed with the SEC on 15 November 2012.
Revenue
$933 million
-2.9% on the year
FY2008FY2012
Operating margin
38.8%
44.7% a year earlier
FY2008FY2012
Net income
$264 million
-14.5% on the year
FY2008FY2012
Diluted EPS
$2.46
-10.5% on the year
FY2008FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
933
961
923
-2.9%
Cost of revenue
92.0
111
132
-17.2%
Gross profit
841
850
791
-1.0%
Gross margin
90.1%
88.4%
85.7%
Research and development
140
124
105
+13.1%
Operating income
362
430
429
-15.8%
Operating margin
38.8%
44.7%
46.5%
Interest expense
0.2
-1.0
0.7
Pre-tax income
369
441
437
-16.3%
Income tax
104
130
154
-20.1%
Effective tax rate
28.1%
29.5%
35.3%
Net income
264
309
283
-14.5%
Net margin
28.3%
32.2%
30.7%
Diluted EPS
$2.46
$2.75
$2.46
-10.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
390
404
327
-3.4%
Capital expenditure
167
47.4
37.5
+253.3%
Free cash flow
222
356
290
-37.6%
Free cash flow margin
23.8%
37.1%
31.4%
Cash from investing
-195
-237
-44.4
Cash from financing
-254
-162
-185
Depreciation and amortisation
43.9
44.0
34.9
-0.3%
Share-based compensation
47.6
43.7
28.8
+9.0%
Buybacks
268
192
241
+39.4%
Dividends paid
0.0
0.0
n/a
Diluted shares, weighted
108m
113m
115m
-4.5%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
1,720
1,664
1,474
+3.4%
Non-controlling interest
23.0
21.8
20.9
+5.2%
Debt
0.0
0.0
0.0
Other liabilities
218
199
217
+9.3%
Total liabilities and equity
1,961
1,884
1,712
+4.1%
Fixed assets
255
117
94.1
+117.5%
Goodwill
281
263
265
+6.9%
Intangible assets
56.5
51.6
67.0
+9.6%
Investments
664
664
493
+0.0%
Cash and equivalents
493
552
546
-10.7%
Receivables
43.5
61.8
54.3
-29.6%
Inventory
16.7
26.2
28.3
-36.4%
Other assets
151
149
165
+1.6%
Total assets
1,961
1,884
1,712
+4.1%
10-K for the year ended 28 September 2012, filed 15 November 2012: the filing.